Risks of cancer due to a single BRCA1 mutation in an extended Utah kindred

Familial Cancer

Volumn 6, Issue 1, 2007, Pages 63-71

  Vogl, Florian D ^a   Badzioch, Mike D ^b   Steele, Linda ^c   Neuhausen, Susan L ^c   Goldgar, David E ^d  

^a FRANZ TAPPEINER HOSPITAL   (Italy)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

BRCA1; Breast ovarian cancer; Cancer risk; Extended pedigree; Penetrance estimation; Single mutation

Indexed keywords

BRCA1 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER LOCALIZATION; CANCER RISK; DISEASE ASSOCIATION; FEMALE; GENE LOCATION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MAXIMUM LIKELIHOOD METHOD; ONCOGENE; OVARY CANCER; PEDIGREE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; UNITED STATES;

BREAST NEOPLASMS; FEMALE; FOUNDER EFFECT; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; KAPLAN-MEIERS ESTIMATE; LIKELIHOOD FUNCTIONS; MUTATION; NEOPLASMS, SECOND PRIMARY; OVARIAN NEOPLASMS; PEDIGREE; PENETRANCE; RISK ASSESSMENT; UTAH;

EID: 33847127414     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-006-9106-8     Document Type: Article

References (18)

1. Goldgar DE, Fields P, Lewis CM et al (1994) A large kindred with 17q-linked breast and ovarian cancer: genetic, phenotypic, and genealogical analysis. J Natl Cancer Inst 86:200-209
2. Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56:265-271
3. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE (1994) Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343:692-695
4. Struewing JP, Hartge P, Wacholder S et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401-1408
5. Hopper JL, Southey MC, Dite GS et al (1999) Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiol Biomarkers Prev 8:741-747
6. Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117-1130
7. Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
8. Botkin JR, Croyle RT, Smith KR et al (1996) A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing. J Natl Cancer Inst 88:872-882
9. StataCorp (1999) Stata statistical software [release 6.0]. Stata Corporation, College Station, TX
10. Hasstedt SJ, Cartwright PE (1989) Pedigree analysis package. University of Utah, Salt Lake City, UT
11. Hodge SE, Elston RC (1994) Lods, wrods, and mods: the interpretation of lod scores calculated under different models. Genet Epidemiol 11:329-342
12. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (eds) (1997) Cancer incidence in five continents, vol VII. IARC Scientific Pub No 143. IARC, Lyon,
13. Cannings C, Thompson EA (1977) Ascertainment in the sequential sampling of pedigrees. Clin Genet 12:208-212
14. Begg CB (2002) On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 94:1221-1226
15. Thompson D, Easton D (2002) Variation in BRCA1 cancer risks by mutation position. Cancer Epidemiol Biomarkers Prev 11:329-336
16. Langston AA, Stanford JL, Wicklund KG, Thompson JD, Blazej RG, Ostrander EA (1996) Germ-line BRCA1 mutations in selected men with prostate cancer. Am J Hum Genet 58:881-884
17. Thompson D, Easton DF (2002) Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94:1358-1365
18. Chen-Shtoyerman R, Figer A, Fidder HH et al (2001) The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients Br J Cancer 84:475-477